CSIMarket
 

X4 Pharmaceuticals Inc  (XFOR)
Other Ticker:  
 

X4 Pharmaceuticals Inc's Working Capital Per Sales

XFOR's Working Capital and Revenue growth



XFOR Working Capital Per Revenue (Mar 31 2024)
I. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
III. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Working Capital Change -39.63 % 112.41 % 298.96 % 40.15 % 43.54 %
Y / Y Revenue Change - - - - -
Working Capital Per Revenue - - - - -
Total Ranking # # # # #
Seq. Working Capital Change -47.45 % -2.36 % 58.35 % -25.7 % 84.89 %
Seq. Revenue Change - - - - -





Comment on XFOR's Working Capital Per Revenue in the first quarter 2024
X4 Pharmaceuticals Inc's Working Capital Per Revenue sequentially grew to 84.89 during the Q1 2024, above the company average.

Within Healthcare sector X4 Pharmaceuticals Inc has achieved the lowest Working Capital Per Revenue. While Working Capital Per Revenue remained unchanged in the Q1 2024 relative to the prior quarter at no. .
Working Capital Per Revenue Ranking
Within: No.
Industry #
Sector #
S&P 500 #


Working Capital Per Revenue Statistics
High Average Low
0
0
0
 



Financial Statements
X4 Pharmaceuticals Inc's Working Capital $ 65 Millions Visit XFOR's Balance sheet
X4 Pharmaceuticals Inc's Revenues $ 0 Millions Visit XFOR's Income Statement
Where are XFOR's Sales coming from? Visit XFOR's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Mar 31 2024, within Healthcare Sector Working Capital Per Revenue
Date modified: 2024-05-08T15:34:55+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com